Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Apollonio

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2012
In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptorsEleonora Fonte, Benedetta Apollonio, Lydia Scarfò, et al.
Blood|February 23, 2008
Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergyMarta Muzio, Benedetta Apollonio, Cristina Scielzo, et al.
Cancers|April 23, 2022
The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic OpportunitiesIlaria Saltarella, Benedetta Apollonio, Aurelia Lamanuzzi, et al.
Journal of Visualized Experiments : Jove|October 29, 2014
From a 2DE-gel spot to protein function: lesson learned from HS1 in chronic lymphocytic leukemiaBenedetta Apollonio, Maria Teresa Sabrina Bertilaccio, Umberto Restuccia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 10, 2016
B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4Stavroula Ntoufa, Nikos Papakonstantinou, Benedetta Apollonio, et al.
Blood|April 28, 2016
Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cellsDawn T Smallwood, Benedetta Apollonio, Shaun Willimott, et al.
Frontiers in Immunology|August 18, 2025
Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot studySimona De Summa, Giuseppe De Palma, Veronica Ghini, et al.
Blood|April 23, 2015
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, et al.
Frontiers in Immunology|May 27, 2024
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?Teresa Squicciarini, Rossella Villani, Benedetta Apollonio, et al.
Blood|January 18, 2013
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemiaElisa ten Hacken, Cristina Scielzo, Maria T S Bertilaccio, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2012
In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptorsEleonora Fonte, Benedetta Apollonio, Lydia Scarfò, et al.
Blood|February 23, 2008
Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergyMarta Muzio, Benedetta Apollonio, Cristina Scielzo, et al.
Cancers|April 23, 2022
The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic OpportunitiesIlaria Saltarella, Benedetta Apollonio, Aurelia Lamanuzzi, et al.
Journal of Visualized Experiments : Jove|October 29, 2014
From a 2DE-gel spot to protein function: lesson learned from HS1 in chronic lymphocytic leukemiaBenedetta Apollonio, Maria Teresa Sabrina Bertilaccio, Umberto Restuccia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 10, 2016
B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4Stavroula Ntoufa, Nikos Papakonstantinou, Benedetta Apollonio, et al.
Blood|April 28, 2016
Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cellsDawn T Smallwood, Benedetta Apollonio, Shaun Willimott, et al.
Frontiers in Immunology|August 18, 2025
Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot studySimona De Summa, Giuseppe De Palma, Veronica Ghini, et al.
Blood|April 23, 2015
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, et al.
Frontiers in Immunology|May 27, 2024
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?Teresa Squicciarini, Rossella Villani, Benedetta Apollonio, et al.
Blood|January 18, 2013
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemiaElisa ten Hacken, Cristina Scielzo, Maria T S Bertilaccio, et al.
Pageof 4